| Name | Title | Contact Details |
|---|---|---|
Carlos Ng |
Vice President of Information Technology | Profile |
Sean Riley |
Chief Information Officer | Profile |
InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany as well as Ann Arbor, Michigan. InflaRx is listed on the Nasdaq Global Select Market in the United States under the trading symbol “IFRX”.
Molecular NeuroImaging is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Qosina is one of the leading medical device component suppliers of OEM components to medical and pharmaceutical industries. Explore our products today.
WN Pharmaceuticals Ltd is a Coquitlam, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our proprietary and vertically integrated technology solutions empower clients to improve patient outcomes and enhance medication adherence through improved access (virtual care and MTM), owned pharmacy infrastructure and physician network, information...